1. Hydrogel will not be filled in September. NVIV has never met guidance. So there is no reason to believe things will be any different in the future because management is still the same.
2. Uplisting was delayed "indefinitely" for a reason, meaning it is going to take awhile. Additionally, uplisting alone has limited upside because of weak management. I do not think the CEO is a favorite among institutional investors.
3. Finally, I am skeptical of clinical trials starting in early fall (and what does that mean anyways?). I would not be surprised to see that deadline start to slide out further and further as it gets closer.
exactly who are you to be making predictions like this??? do you have ESP? You are of the same "ilk" who yakked over and over again last winter that NVIV would never get the FDA go ahead to do the human trials/get orphan drug status etc etc? I have really had it with "bashers" like you--you represent the selfish/imbecile crowd who are only in this to make a "quick buck" and don't look at the long term picture-the distinct likelihood that people who have been confined to wheelchairs or are looking at a future as a para/quadriplegic now have hope where there wasn't hope before---thank GOD that yahoo has an ignore user feature----consider yourself IGNORED
Sentiment: Strong Buy